Treatment of osteoporosis with bisphosphonates

被引:57
作者
Watts, NB
机构
[1] Emory Clin Inc, Osteoporsis & Metab Bone Dis Program, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Atlanta, GA 30322 USA
关键词
D O I
10.1016/S0889-8529(05)70014-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Along with drugs such as Estrogen and calcitonin, bisphosphonates alter bone remodeling by reducing bone resorption and are considered antiresorptive agents. This article discusses several bisphosphonates that are effective for preventing bone loss associated with estrogen deficiency, glucocorticoid treatment, and immobilization, and for at least partially reversing bone loss in patients with postmenopausal osteoporosis and steroid-induced osteoporosis.
引用
收藏
页码:419 / +
页数:22
相关论文
共 157 条
[1]   THE ACUTE-PHASE RESPONSE AFTER BISPHOSPHONATE ADMINISTRATION [J].
ADAMI, S ;
BHALLA, AK ;
DORIZZI, R ;
MONTESANTI, F ;
ROSINI, S ;
SALVAGNO, G ;
LOCASCIO, V .
CALCIFIED TISSUE INTERNATIONAL, 1987, 41 (06) :326-331
[2]   MINERALIZATION DEFECTS WITH PAMIDRONATE THERAPY FOR PAGETS-DISEASE [J].
ADAMSON, BB ;
GALLACHER, SJ ;
BYARS, J ;
RALSTON, SH ;
BOYLE, IT ;
BOYCE, BF .
LANCET, 1993, 342 (8885) :1459-1460
[3]   INFLUENCE OF DISODIUM ETIDRONATE ON CLINICAL AND LABORATORY MANIFESTATIONS OF PAGETS-DISEASE OF BONE (OSTEITIS DEFORMANS) [J].
ALTMAN, RD ;
JOHNSTON, CC ;
KHAIRI, MRA ;
WELLMAN, H ;
SERAFINI, AN ;
SANKEY, RR .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (26) :1379-1384
[4]   PRELIMINARY-OBSERVATIONS OF A FORM OF COHERENCE THERAPY FOR OSTEOPOROSIS [J].
ANDERSON, C ;
CAPE, RDT ;
CRILLY, RG ;
HODSMAN, AB ;
WOLFE, BMJ .
CALCIFIED TISSUE INTERNATIONAL, 1984, 36 (03) :341-343
[5]   Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone [J].
ArdenCordone, M ;
Siris, ES ;
Lyles, KW ;
Knieriem, A ;
Newton, RA ;
Schaffer, V ;
Zelenakas, K .
CALCIFIED TISSUE INTERNATIONAL, 1997, 60 (05) :415-418
[6]  
AXELROD DW, 1995, J BONE MINER RES S1, V9, pS136
[7]   Evaluation and management of heterotopic ossification in patients with spinal cord injury [J].
Banovac, K ;
Gonzalez, F .
SPINAL CORD, 1997, 35 (03) :158-162
[8]  
BASSETT CAL, 1969, LANCET, V2, P845
[9]  
Bekker PJ, 1997, J BONE MINER RES, V12, pS474
[10]   Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal function [J].
Berenson, JR ;
Rosen, L ;
Vescio, R ;
Lau, HS ;
Woo, M ;
Sioufi, A ;
Kowalski, O ;
Knight, RD ;
Seaman, JJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (04) :285-290